Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by LMR Partners LLP

LMR Partners LLP lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 66.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,526 shares of the medical equipment provider's stock after selling 7,089 shares during the quarter. LMR Partners LLP's holdings in Intuitive Surgical were worth $1,840,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after buying an additional 360,591 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Intuitive Surgical by 3.2% during the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock worth $4,039,200,000 after purchasing an additional 243,802 shares in the last quarter. Fisher Asset Management LLC lifted its position in shares of Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock worth $2,541,356,000 after purchasing an additional 86,488 shares in the last quarter. Norges Bank acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth about $2,401,493,000. Finally, Invesco Ltd. lifted its position in shares of Intuitive Surgical by 7.7% during the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock worth $2,165,184,000 after purchasing an additional 295,025 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of the business's stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares of the company's stock, valued at approximately $2,793,033.06. The trade was a 60.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the transaction, the director now directly owns 6,371 shares of the company's stock, valued at $3,312,920. The trade was a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders sold 32,700 shares of company stock valued at $16,865,621 in the last 90 days. 0.70% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on ISRG shares. Barclays reduced their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. UBS Group increased their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Royal Bank of Canada reduced their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. Finally, Piper Sandler reduced their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $598.95.

Intuitive Surgical Trading Up 0.6%

Shares of NASDAQ:ISRG traded up $3.32 during midday trading on Friday, hitting $563.60. 1,422,176 shares of the stock were exchanged, compared to its average volume of 1,640,855. The stock has a market cap of $202.00 billion, a P/E ratio of 87.93, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a twelve month low of $393.98 and a twelve month high of $616.00. The company has a 50 day moving average price of $505.22 and a 200-day moving average price of $536.45.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the previous year, the company posted $1.50 EPS. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.